Sunrest Lifescience Ltd Stock Price Today (NSE: SUNREST)
Fundamental Score
Sunrest Lifescience Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Sunrest Lifescience Ltd share price today is ₹40.50, down 3.11% on NSE/BSE as of 7 August 2026. Sunrest Lifescience Ltd (SUNREST) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹30.55 (Cr). The 52-week high for SUNREST share price is ₹57.80 and the 52-week low is ₹32.10. At a P/E ratio of 7.42x, SUNREST is currently trading below its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 22.43% and a debt-to-equity ratio of 0.85.
Sunrest Lifescience Ltd Share Price Chart — NSE/BSE Historical Performance
Sunrest Lifescience Ltd share price chart: 2.53% return over the past month. 52-week high ₹57.80, 52-week low ₹32.10.
Sunrest Lifescience Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹41.80 | ₹43.25 | ₹40.50 | ₹40.50 | 14.40K (Cr) | |
| ₹39.00 | ₹39.00 | ₹39.00 | ₹39.00 | 1.60K (Cr) | |
| ₹36.30 | ₹36.30 | ₹36.30 | ₹36.30 | 1.60K (Cr) | |
| ₹35.50 | ₹36.50 | ₹33.50 | ₹36.50 | 4.80K (Cr) | |
| ₹35.50 | ₹35.50 | ₹35.50 | ₹35.50 | 1.60K (Cr) | |
| ₹35.00 | ₹35.00 | ₹35.00 | ₹35.00 | 1.60K (Cr) | |
| ₹35.00 | ₹35.00 | ₹35.00 | ₹35.00 | 1.60K (Cr) | |
| ₹35.60 | ₹35.60 | ₹35.60 | ₹35.60 | 3.20K (Cr) | |
| ₹34.00 | ₹34.00 | ₹34.00 | ₹34.00 | 1.60K (Cr) | |
| ₹36.00 | ₹36.00 | ₹35.00 | ₹35.00 | 4.80K (Cr) |
Sunrest Lifescience Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹36.30 | ₹43.25 | ₹36.30 | ₹40.50 | +11.57% | |
| ₹35.60 | ₹36.50 | ₹33.50 | ₹36.50 | +2.53% | |
| ₹36.00 | ₹36.00 | ₹34.00 | ₹34.00 | -5.56% | |
| ₹35.50 | ₹41.00 | ₹35.00 | ₹35.00 | -1.41% | |
| ₹37.00 | ₹37.50 | ₹35.55 | ₹36.30 | -1.89% | |
| ₹44.60 | ₹47.65 | ₹35.20 | ₹37.00 | -17.04% | |
| ₹34.60 | ₹43.90 | ₹33.50 | ₹43.80 | +26.59% | |
| ₹45.00 | ₹45.00 | ₹32.10 | ₹33.00 | -26.67% | |
| ₹42.20 | ₹43.00 | ₹41.55 | ₹41.55 | -1.54% | |
| ₹46.50 | ₹50.00 | ₹43.00 | ₹43.00 | -7.53% | |
| ₹47.20 | ₹47.20 | ₹40.15 | ₹42.00 | -11.02% | |
| ₹49.20 | ₹49.20 | ₹44.00 | ₹47.20 | -4.07% |
AI Research Briefing
Powered by Gemini · 2026-04-09
Micro-cap pharma play hinging on a successful rights issue, but liquidity risk and promoter selling make it a dangerous bet.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Sunrest Lifescience is undertaking a rights issue to raise Cr, offering 4.29 million shares at each, including a premium. The issue opened on April 2, 2026, and closes on April 30, 2026. The rights entitlement ratio is 1:1.
CORE STORY (THE REAL GAME)
Sunrest is a micro-cap pharma company attempting to scale via rights issue. This is a capital raise, not a turnaround, and the market will likely punish any operational misses.
- Rights issue open until April 30, 2026
- Indian pharma sector projected to reach $130 billion by 2030
- Recent board meetings indicate focus on fund raising
- Successful closure of rights issue
- Significant order wins or partnerships
- Positive regulatory changes in the pharma sector
- Micro/SME cap = liquidity risk
- Promoter holding decreased by 16.41%
- Negative cash flow from operations in recent fiscals
Promoter selling suggests lack of confidence.
Indian pharma industry is growing, but faces global pricing pressures.
No Free Cash Flow reported
Next 3-6 months depend on successful deployment of rights issue proceeds. Failure to improve financials will lead to further downside.
Primary Thesis Risk
Failure of rights issue or inability to effectively deploy capital.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Sunrest Lifescience Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Sunrest Lifescience Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SUNREST across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Strong Return on Equity (22.43%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (28.55%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Attractive Valuation (P/E: 7.42 vs Industry: 34.89)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Strong Interest Coverage (8.12x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (53.50%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
1 factors identified
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Sunrest Lifescience Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Sunrest Lifescience Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
27.8/100 | ₹40.50₹41 | ₹30.55₹30.55 | 7.42Average 7.4 Average | 22.43%Excellent 22.43% Excellent | 28.55%Excellent 28.55% Excellent | 0.85Good 0.8 Good | — — | — — | 0.00% | |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1990.50₹1991 | ₹468821.49₹468821.49 | 37.73Average 37.7 Average | 15.95%Good 15.95% Good | 20.53%Excellent 20.53% Excellent | 0.06Excellent 0.1 Excellent | 16.75%Excellent 16.75% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 56.3/100 | ₹8056.00₹8056 | ₹193163.97₹193163.97 | 73.64Average 73.6 Average | 16.53%Good 16.53% Good | 21.96%Excellent 21.96% Excellent | 0.00Excellent 0.0 Excellent | 5.71%Good 5.71% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹5122.80₹5123 | ₹169902.02₹169902.02 | 77.52Average 77.5 Average | 27.43%Excellent 27.43% Excellent | 15.19%Good 15.19% Good | 1.79Average 1.8 Average | 12.07%Good 12.07% Good | 11.80%Good 11.80% Good | 0.76% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 40.2/100 | ₹1473.20₹1473 | ₹116131.81₹116131.81 | 30.51Average 30.5 Average | 11.60%Average 11.60% Average | 15.49%Good 15.49% Good | 0.02Excellent 0.0 Excellent | 9.94%Good 9.94% Good | 8.01%Good 8.01% Good | 0.90% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1078.30₹1078 | ₹115375.77₹115375.77 | 21.26Average 21.3 Average | 21.25%Excellent 21.25% Excellent | 21.14%Excellent 21.14% Excellent | 0.46Excellent 0.5 Excellent | 18.77%Excellent 18.77% Excellent | 12.45%Good 12.45% Good | 0.09% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 83.4/100 | ₹2415.00₹2415 | ₹113976.53₹113976.53 | 20.04Average 20.0 Average | 28.68%Excellent 28.68% Excellent | 29.93%Excellent 29.93% Excellent | 0.29Excellent 0.3 Excellent | 37.02%Excellent 37.02% Excellent | 13.02%Good 13.02% Good | 0.72% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2469.60₹2470 | ₹105053.91₹105053.91 | 52.29Average 52.3 Average | 13.12%Average 13.12% Average | 13.50%Average 13.50% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 41/100 | ₹1148.10₹1148 | ₹102660.46₹102660.46 | 25.62Average 25.6 Average | 11.22%Average 11.22% Average | 13.04%Average 13.04% Average | 0.20Excellent 0.2 Excellent | 15.44%Excellent 15.44% Excellent | 12.09%Good 12.09% Good | 0.65% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1580.20₹1580 | ₹90035.87₹90035.87 | 25.38Average 25.4 Average | 10.06%Average 10.06% Average | 12.80%Average 12.80% Average | 0.21Excellent 0.2 Excellent | 0.80%Average 0.80% Average | 6.32%Good 6.32% Good | 0.26% |
Laurus Labs LtdLaurus Labs Ltd... LAURUSLABS • 540222 | 34.1/100 | ₹1816.20₹1816 | ₹84016.75₹84016.75 | 93.94Average 93.9 Average | 18.30%Good 18.30% Good | 17.76%Good 17.76% Good | 0.48Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price468821.49 Cr
- Divis Laboratories Ltd share price193163.97 Cr
- Torrent Pharmaceuticals Ltd share price169902.02 Cr
- Cipla Ltd share price116131.81 Cr
- Zydus Lifesciences Ltd share price115375.77 Cr
Sunrest Lifescience Ltd PE Ratio History
Historical price-to-earnings ratio for SUNREST — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹0.68 | ₹51.50 | 75.7x |
| FY 2023 | ₹4.76 | ₹63.45 | 13.3x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Sunrest Lifescience Ltd Quarterly Performance
Latest quarterly metrics for SUNREST — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
N/A
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
N/A
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Sunrest Lifescience Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for SUNREST — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Sunrest Lifescience Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Sunrest Lifescience Ltd (SUNREST) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Sunrest Lifescience Ltd
About SUNREST (Sunrest Lifescience Ltd)
Sunrest Lifescience Ltd (SUNREST) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pharmaceuticals sector with a... current market capitalisation of ₹30.55 (Cr). Sunrest Lifescience Ltd has delivered a Return on Equity (ROE) of 22.43% and a ROCE of 28.55%. The debt-to-equity ratio stands at 0.85, reflecting the company's capital structure. Investors tracking SUNREST share price can monitor key metrics including P/E ratio, promoter holding of 53.50%, and quarterly earnings growth.
Company Details
SUNREST Share Price: Frequently Asked Questions
What is the current share price of Sunrest Lifescience Ltd?
Sunrest Lifescience Ltd (SUNREST) trades at ₹40.50 on NSE. Market cap ₹30.55 (Cr). Educational data only.
What is the P/E ratio of Sunrest Lifescience Ltd?
Sunrest Lifescience Ltd has a P/E of 7.42x vs industry average 34.89x.
What is the Bull Run score for Sunrest Lifescience Ltd?
Sunrest Lifescience Ltd has a Bull Run score of 27.8/100 based on 25+ financial parameters.
Does Sunrest Lifescience Ltd pay dividends?
Sunrest Lifescience Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Sunrest Lifescience Ltd?
Sunrest Lifescience Ltd has ROE of 22.43%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Sunrest Lifescience Ltd?
Sunrest Lifescience Ltd has debt-to-equity of 0.85.
Is Sunrest Lifescience Ltd a good investment?
Bull Run gives Sunrest Lifescience Ltd a score of 27.8/100. This is not investment advice — consult a SEBI-registered advisor.